Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $66
Morgan Stanley analyst Drew Ranieri maintains Globus Medical (NYSE:GMED) with a Equal-Weight and raises the price target from $62 to $66.
Short Volatility Alert: Globus Medical, Inc.
On Thursday, shares of Globus Medical, Inc. (NYSE: GMED) experienced volatile short activity. After the activity, the stock price went up +1.83% to $62.78.
The overall sentiment for GMED has been Bearish.
Analyst Ratings for Globus Medical
Globus Medical (NYSE:GMED) has observed the following analyst ratings within the last quarter:
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $71
Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $76 to $71.
What 5 Analyst Ratings Have To Say About Globus Medical
Globus Medical (NYSE:GMED) has observed the following analyst ratings within the last quarter:
Globus Medical’s Return On Invested Capital Insights
Pulled from Benzinga Pro data, Globus Medical (NYSE:GMED) posted Q1 earnings of $38.08 million, an increase from Q4 of 152.11%. Sales dropped to $230.55 million, a 7.79% decrease between quarters.
Morgan Stanley Maintains Equal-Weight on Globus Medical, Lowers Price Target to $68
Morgan Stanley maintains Globus Medical (NYSE:GMED) with a Equal-Weight and lowers the price target from $74 to $68.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.